More study resources

About this exam

The Iraqi Board in Clinical Pharmacy is a postgraduate specialty qualification for pharmacists who want to practise as clinical pharmacists within Iraq's hospital, teaching-hospital and ministry health systems. Candidates are typically pharmacy graduates who have completed, or are completing, structured residency-style training, and who are expected to make independent therapeutic decisions on wards rather than only dispense. The assessment is deliberately broad because the role is broad: it tests applied clinical pharmacokinetics and pharmacodynamics, evidence-based pharmacotherapy across cardiovascular, renal, infectious, endocrine, respiratory, gastrointestinal, hepatic, neuropsychiatric, oncologic and immunologic disease, plus patient assessment and laboratory interpretation, medication safety and pharmacovigilance, biostatistics and drug information, and Iraqi pharmacy law, regulation and professional ethics. Examiners are usually interested in reasoning rather than recall, so the strongest candidates can defend a monitoring plan, a dose adjustment or a stewardship decision under questioning. Preparation should combine a current therapeutics textbook or guideline set with local formulary and national treatment guidance, daily ward exposure with a logbook of cases, and repeated practice in the formats used: multiple-choice papers, written and essay answers, and oral or OSCE-style stations where a case is presented and you are asked to justify your plan aloud. Confirm all administrative details, including dates, fees and eligibility, directly with the official examining body.

What you'll study

Common questions

About Iraqi Board Clinical Pharmacy preparation

What exactly is the Iraqi Board in Clinical Pharmacy awarded for?

It certifies specialty-level competence in clinical pharmacy, distinguishing a general pharmacy licence from advanced ward-based practice. Holders are expected to lead therapeutic decision-making, run medication reviews, support antimicrobial stewardship and teach juniors. Verify current recognition and registration rules with the official body, since the practical scope attached to the title can change.

How is the examination delivered?

Expect a multi-format assessment rather than a single paper: multiple-choice questions, written or essay-style answers, and oral or OSCE-style clinical stations with a presented case. The oral component is where many candidates are separated, because you must justify monitoring and dose decisions aloud. Confirm the current structure with the official body.

How many questions are there, how long does it take, and what does it cost?

Those figures are set by the examining body and are not fixed permanently, so any number you read online may be out of date. The official body publishes the current question counts, timing, fees and passing standard. Check its website or correspondence directly before you plan study schedules or budget.

How difficult is it in practice?

The content is not exotic; the difficulty is integration under pressure. Candidates who have memorised guidelines but never had to defend a monitoring plan aloud often struggle in oral stations. Those who have worked cases, adjusted doses for renal function and discussed stewardship decisions with seniors usually find the reasoning manageable. Depth of clinical exposure matters more than extra reading.

If I fail a component, can I retake it, and how long is the pass valid?

Retake rules, component-level resits and validity periods are administrative matters determined by the examining body and can be revised. Do not rely on secondhand accounts. Ask the official body in writing about resit eligibility, waiting periods and whether a partial pass is carried forward, and keep that correspondence.

In what order should I study the domains?

Start with pharmacokinetics and pharmacodynamics, because dosing and monitoring logic underpins every other domain. Then take cardiovascular and renal together, followed by infectious diseases and stewardship, then endocrine and respiratory and gastrointestinal. Leave law, ethics, biostatistics and drug information for later, but do not skip them; they are easy marks that candidates routinely neglect.

Why do candidates commonly fail?

Three recurring reasons: neglecting the smaller domains such as biostatistics, drug information and Iraqi law; answering oral stations with a diagnosis instead of a plan, monitoring parameters and follow-up; and ignoring local formulary and national guidance in favour of foreign guidelines. A fourth is poor laboratory interpretation, particularly renal function, electrolytes and liver enzymes.

How should I prepare for the oral and OSCE-style stations?

Practise aloud with a colleague using real cases from your ward. Structure every answer as assessment, problem list, drug and dose with justification, monitoring parameters, and follow-up timing. Rehearse renal and hepatic dose adjustments and common interactions until they are automatic. Record yourself and check that you state how you will know the therapy is working.

Do I need formal residency training before sitting?

Eligibility conditions, including required training or experience, are set by the official body and are not safe to assume. Some candidates come through structured residency programmes, others through hospital posts. Confirm your eligibility in writing before investing in preparation, and keep documentation of your training and case experience.

Where can I confirm dates, eligibility and current rules?

Only from the official examining body. This page is an independent study resource and has no affiliation with the board, so it cannot confirm logistics. Use the official body's website and any written correspondence it issues as the authoritative source, and treat study guides, forums and social media posts as unverified.